GlobeNewswire

Med Mart Launches MedMartSupply.com, Expanding More Than 30 Years of Healthcare Experience Into Everyday Medical Supplies
08/09/2026
New ecommerce site extends Med Mart’s healthcare expertise into everyday medical supplies, health and wellness products for consumers, caregivers and businesses. CINCINNATI, Ohio, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Med [...]
Clariane announces the success of its 2032 €500 million senior notes offering and a new €700m syndicated RCF (5 years, same terms) – subject to final settlement of the notes
08/09/2026
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, CANADA, JAPAN OR AUSTRALIA OR ANY OTHER JURISDICTION IN WHICH IT WOULD BE UNLAWFUL TO DO SO Clariane [...]
Clariane annonce le succès de l’offre de 500 M€ d’obligations senior et l’accord de ses partenaires bancaires pour la mise en place d’un nouveau crédit syndiqué RCF (5 ans, mêmes termes) de 700 M€ – soumis au règlement des obligations
08/09/2026
NE PAS DIFFUSER, PUBLIER OU DISTRIBUER, DIRECTEMENT OU INDIRECTEMENT, AUX ÉTATS-UNIS D’AMÉRIQUE, AU CANADA, AU JAPON OU EN AUSTRALIE, OU DANS TOUTE AUTRE JURIDICTION OU IL EST ILLÉGAL DE DIFFUSER, DE PUBLIER OU DE [...]
Alignment Health Plan and Hoag Health System Increase Access to Award-Winning Care for Orange County Seniors
08/09/2026
Expanded provider relationship increases access to Hoag physicians, hospitals and specialty programs beginning Jan. 1, 2027 ORANGE, Calif., Sept. 08, 2026 (GLOBE NEWSWIRE) -- Alignment Health Plan, an award-winning [...]
Beacon Behavioral Partners Adds Prime Psychiatry and Invicta Healthcare, Deepening Dallas-Fort Worth Network
08/09/2026
Seven additional clinic locations grow Beacon's physician-led network across North Texas, enhancing innovation through partnership PLANO, Texas, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Beacon Behavioral Partners (BBP), a [...]
Following R3ALM Strategic Acquisition, Vystar Executes Sale of Remaining Vytex Inventory
08/09/2026
BOSTON, MA, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Vystar Corporation (OTCQB: VYST) today announced the completion of a sale of substantially all remaining inventory associated with its Vytex business as the Company [...]
Akari Therapeutics Selected to Showcase Novel PH1 ADC Payload Platform at Leading Global Oncology, ADC and Healthcare Forums
08/09/2026
Company invited to present alongside global pharmaceutical, biotechnology and industry leaders at five high-profile U.S. and China conferences in September CEO Abizer Gaslightwala to deliver keynote and featured [...]
Vericel to Present at the 24th Annual Morgan Stanley Global Healthcare Conference on Tuesday, September 15, 2026
08/09/2026
BURLINGTON, Mass., Sept. 08, 2026 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that the Company will present [...]
Optimi Health to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
08/09/2026
VANCOUVER, British Columbia, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Optimi Health Corp. (Nasdaq: OPTH) (CSE: OPTI) (“ Optimi ” or the “ Company ”), a commercial-stage pharmaceutical manufacturer of regulated psychedelic [...]
Quoin Pharmaceuticals Announces FDA Grants Rare Pediatric Disease Designation for QRX003 in Peeling Skin Syndrome
08/09/2026
Second Rare Pediatric Disease (RPD) Designation for QRX003 FDA Previously Granted RPD Designation for QRX003 in Netherton Syndrome If a New Drug Application (NDA) for QRX003 Is Approved for Peeling Skin Syndrome, Quoin [...]
Lifeward Publishes Updated Investor Presentation Highlighting Commercial Growth Strategy
08/09/2026
HUDSON, Mass. and YOKNEAM ILLIT, Israel, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) (“Lifeward” or the “Company”), a diversified biomedical innovation company with a portfolio of commercialized [...]
Surrozen Announces Submission of IND Application for SZN-8141 for the Treatment of Diabetic Macular Edema
08/09/2026
SOUTH SAN FRANCISCO, Calif., Sept. 08, 2026 (GLOBE NEWSWIRE) -- Surrozen, Inc. (Surrozen or the Company) (Nasdaq: SRZN), a biotechnology company pioneering targeted therapeutics to harness the power of Wnt signaling to [...]
Merakris Therapeutics Launches Patent-Pending AmnioSurge™ With 360 Medical, Opening New Surgical Revenue Channel
08/09/2026
Procedure-specific biologic technology combines surgeon training, scalable tissue processing and a capital-efficient commercialization model RESEARCH TRIANGLE PARK, N.C., Sept. 08, 2026 (GLOBE NEWSWIRE) -- Merakris [...]
A Micro-Cap Biotech Just Cleared a Milestone Most Never Reach
08/09/2026
AUSTIN, Texas, Sept. 08, 2026 (GLOBE NEWSWIRE) -- BioMedWire Editorial Coverage : Multiple sclerosis (“MS”) drugs on the market today can slow the disease down, but none of them stop it, and none of them give patients [...]
Tempest to Present at the H.C. Wainwright 28th Annual Global Investment Conference
08/09/2026
BRISBANE, Calif., Sept. 08, 2026 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST) (“Tempest”), a clinical-stage biotechnology company pioneering the development of advanced in vivo CAR-T therapies for [...]
PDS Biotech Announces up to $22.55 Million Financing Led by Dr. Patrick Soon-Shiong, Founder of NantWorks
08/09/2026
Dr. Soon-Shiong will Join PDS Biotech’s Board of Directors PDS Biotech Plans to Progress Development of PDS0301 Immunocytokine in Solid Tumors PRINCETON, N.J., Sept. 08, 2026 (GLOBE NEWSWIRE) -- PDS Biotechnology [...]
CRISPR Therapeutics to Present at the Morgan Stanley 24th Annual Global Healthcare Conference
08/09/2026
ZUG, Switzerland and BOSTON, Sept. 08, 2026 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP) today announced that members of its senior management team will present at the Morgan Stanley 24th Annual Global [...]
Can-Fite Reports Q2 2026 Financial Results and Ongoing Clinical Progress Highlighting Longer-Than-Anticipated Overall Survival in Ongoing Pivotal Phase III Liver Cancer Study
08/09/2026
RAMAT GAN, Israel, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company developing a pipeline of proprietary small molecule drugs targeting oncological [...]
Veru Advances Oral Sabizabulin Following Positive Preclinical Data Showing Potent Anticancer Activity in Human Daraxonrasib (Revolution Medicines’ RASONQUE™) Resistant Pancreatic Cancer into a Planned Phase 2 Clinical Trial
08/09/2026
--New positive preclinical studies show that sabizabulin can overcome drug resistance to daraxonrasib with potent anticancer efficacy (IC50=18.2nM) in daraxonrasib resistant human pancreatic cancer cell line which is a [...]

Pages

Other news

Test 2

Lorem ipsum

Test 1

Lorem upsum